CIK 0001716947 · Non-accelerated filer<br>Smaller reporting company
Ensysce Biosciences, Inc.
Sign in to watch- Ticker
- ENSC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 822755287
- Phone
- (858) 263-4196
- Business address
- 7946 IVANHOE AVENUE, SUITE 201, LA JOLLA, CA, 92037
- Former names
- Leisure Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-07 | GOWER BOB G Director | Purchase | +400,000 | $0.50 | $198K | 916,740 |
| 2026-04-23 | GOWER BOB G Director | Purchase | +508,614 | $0.48 | $246K | 516,740 |
| 2026-04-23 | GOWER BOB G Director | Conversion · Warrant | +254,307 | 289,836 | ||
| 2023-03-02 | GOWER BOB G Director | Purchase | +90,287 | $0.49 | $44K | 1,222,682 |
| 2023-03-01 | GOWER BOB G Director | Purchase | +270,000 | $0.48 | $129K | 1,132,395 |
| 2023-02-28 | GOWER BOB G Director | Purchase | +109,300 | $0.49 | $53K | 862,395 |
| 2022-12-09 | GOWER BOB G Director | Purchase | +357,143 | $1.40 | $500K | 753,095 |
| 2022-12-09 | GOWER BOB G Director | Grant or award · Warrants | +714,286 | 716,365 | ||
| 2022-06-23 | Chang William H Director | Grant or award · Stock Option | +15,000 | 35,000 | ||
| 2022-06-23 | Martin Steven Robert Director | Grant or award · Stock Option | +15,000 | 100,850 | ||
| 2022-06-23 | Rauch Lee M. Director | Grant or award · Stock Option | +15,000 | 35,000 | ||
| 2022-06-23 | GOWER BOB G Director | Grant or award · Stock Option | +15,000 | 41,585 | ||
| 2022-06-23 | Rosebraugh Curtis Director | Grant or award · Stock Option | +20,000 | 35,000 | ||
| 2022-06-23 | Benton Andrew Director | Grant or award · Stock Option | +15,000 | 100,850 | ||
| 2022-06-23 | Levin Adam Director | Grant or award · Stock Option | +15,000 | 35,000 | ||
| 2022-05-26 | Kirkpatrick Lynn Chief Executive Officer | Purchase | +27,000 | $0.53 | $14K | 381,851 |
| 2022-05-25 | Kirkpatrick Lynn Chief Executive Officer | Purchase | +70,000 | $0.49 | $34K | 354,851 |
| 2022-02-17 | Kirkpatrick Lynn Chief Executive Officer | Grant or award · Stock Option | +200,000 | 2,516,939 | ||
| 2022-02-17 | Humphrey David Carl Chief Financial Officer | Grant or award · Stock Option | +80,000 | 80,000 | ||
| 2022-02-17 | Birkett Kevin Geoffrey Chief Commercial Officer | Grant or award · Stock Option | +50,000 | 50,000 |
Page 1 of 4 · 75 trades